Suppr超能文献

AEBP1基因沉默通过PRKCA-PI3K-Akt轴调节神经元铁死亡和小胶质细胞M2极化来保护免受脑缺血/再灌注损伤。

AEBP1 Silencing Protects Against Cerebral Ischemia/Reperfusion Injury by Regulating Neuron Ferroptosis and Microglia M2 Polarization Through PRKCA-PI3K-Akt Axis.

作者信息

Zhang Yafen, Li Yan, Liu Fengli

机构信息

Department of Neurosurgery, Yulin Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, Yulin, China.

Emergency Department, Affiliated Hospital of Medical College of Hebei University of Engineering, Handan, China.

出版信息

Drug Dev Res. 2024 Dec;85(8):e70032. doi: 10.1002/ddr.70032.

Abstract

Cerebral ischemia/reperfusion injury is one of the main causes of neuronal damage. Neuron ferroptosis and microglia polarization are considered as critical processes during cerebral ischemia/reperfusion. Adipocyte enhancer-binding protein 1 (AEBP1) usually acts as a transcriptional repressor which is involved in various diseases. However, it is still remains unknown whether AEBP1 could have important roles in regulating the neuron ferroptosis and microglia polarization in cerebral ischemia/reperfusion injury. The oxygen-glucose deprivation and reperfusion (OGD/R)-treated cells and middle cerebral artery occlusion (MCAO)-treated mice were used as in vitro and in vivo models. The differentially expressed factors were analyzed according to GEO datasets. Relative mRNA and protein expression levels were detected by qRT-PCR and western blot analysis. Cell viability was measured by CCK-8 assay. ROS, GSH and iron contents were detected using specifical assay kits. CD26 and CD206 levels were measured by immunofluorescence assay. Inflammatory cytokines were detected by ELISA. The association between AEBP1 and PRKCA was assessed by luciferase reporter and ChIP analyses. The neuron damage in mice was analyzed by TTC staining and neurological deficit score. Transcription factor AEBP1 was increased in OGD/R-treated HT22 and BV2 cells. AEBP1 silencing attenuated OGD/R-induced HT22 cell ferroptosis through increasing cell viability, GSH and GPX4 levels, and decreasing ROS, iron and ACSL4 levels. AEBP1 knockdown promoted microglia M2 polarization by increasing CD206-positive cells and Arg-1 level, and reducing iNOS, TNF-α, IL-1β and IL-6 levels in BV2 cells. AEBP1 transcriptionally repressed PRKCA expression, and further regulated PI3K/Akt signaling activation. Inhibition of PRKCA or PI3K/Akt reversed the effects of AEBP1 silencing on neuron ferroptosis and microglia M2 polarization. AEBP1 downregulation attenuated neuronal damage by decreasing infarct size and deficit scores in MCAO-treated mice. AEBP1 silencing mitigated neuron ferroptosis and promoted microglia M2 polarization through increasing PRKCA and activating PI3K/Akt signaling, indicating the potentially protective action of AEBP1 knockdown in cerebral ischemia/reperfusion injury.

摘要

脑缺血/再灌注损伤是神经元损伤的主要原因之一。神经元铁死亡和小胶质细胞极化被认为是脑缺血/再灌注过程中的关键过程。脂肪细胞增强子结合蛋白1(AEBP1)通常作为一种转录抑制因子,参与多种疾病的发生。然而,AEBP1在脑缺血/再灌注损伤中是否在调节神经元铁死亡和小胶质细胞极化方面发挥重要作用仍不清楚。氧糖剥夺和再灌注(OGD/R)处理的细胞和大脑中动脉闭塞(MCAO)处理的小鼠被用作体外和体内模型。根据GEO数据集分析差异表达因子。通过qRT-PCR和蛋白质印迹分析检测相对mRNA和蛋白质表达水平。通过CCK-8测定法测量细胞活力。使用特定的检测试剂盒检测ROS、GSH和铁含量。通过免疫荧光测定法测量CD26和CD206水平。通过ELISA检测炎性细胞因子。通过荧光素酶报告基因和ChIP分析评估AEBP1与PRKCA之间的关联。通过TTC染色和神经功能缺损评分分析小鼠的神经元损伤。转录因子AEBP1在OGD/R处理的HT22和BV2细胞中增加。AEBP1沉默通过增加细胞活力、GSH和GPX4水平以及降低ROS、铁和ACSL4水平减轻OGD/R诱导的HT22细胞铁死亡。AEBP1敲低通过增加CD206阳性细胞和Arg-1水平以及降低BV2细胞中的iNOS、TNF-α、IL-1β和IL-6水平促进小胶质细胞M2极化。AEBP1转录抑制PRKCA表达,并进一步调节PI3K/Akt信号激活。抑制PRKCA或PI3K/Akt可逆转AEBP1沉默对神经元铁死亡和小胶质细胞M2极化的影响。AEBP1下调通过减小MCAO处理小鼠的梗死面积和缺损评分减轻神经元损伤。AEBP1沉默通过增加PRKCA和激活PI3K/Akt信号减轻神经元铁死亡并促进小胶质细胞M2极化,表明AEBP1敲低在脑缺血/再灌注损伤中具有潜在的保护作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验